[
  {
    "ts": "2025-12-23T01:09:58+00:00",
    "headline": "Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug",
    "summary": "The FDA approved Novo Nordisk's Wegovy pill as the first oral GLP-1 treatment for weight loss. The Danish drug giant jumped overnight.",
    "url": "https://www.investors.com/news/technology/novo-nordisk-stock-jumps-fda-oks-wegovy-pill-first-oral-glp-1-weight-loss-drug/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "8daff7dd-6122-3cb9-ad16-8a3df5fa8764",
      "content": {
        "id": "8daff7dd-6122-3cb9-ad16-8a3df5fa8764",
        "contentType": "STORY",
        "title": "Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug",
        "description": "",
        "summary": "The FDA approved Novo Nordisk's Wegovy pill as the first oral GLP-1 treatment for weight loss. The Danish drug giant jumped overnight.",
        "pubDate": "2025-12-23T01:09:58Z",
        "displayTime": "2025-12-23T01:09:58Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8daff7dd-6122-3cb9-ad16-8a3df5fa8764/novo-nordisk-jumps-as-fda-oks.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/9df63cff834c89a486567ccbf9cf93d9",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YiKgI2utbRoeUo10UfMm9A--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/9df63cff834c89a486567ccbf9cf93d9.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wGfYYRb5xDf1JRG.uzPz.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/9df63cff834c89a486567ccbf9cf93d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/novo-nordisk-stock-jumps-fda-oks-wegovy-pill-first-oral-glp-1-weight-loss-drug/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T00:29:18+00:00",
    "headline": "Why Abivax Stock Was on Fire Today",
    "summary": "Investors were excited about the possibility of a buyout with a high price tag.",
    "url": "https://www.fool.com/investing/2025/12/22/why-abivax-stock-was-on-fire-today/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "332eba4d-b714-3d48-8a2a-a0a1ee18efe1",
      "content": {
        "id": "332eba4d-b714-3d48-8a2a-a0a1ee18efe1",
        "contentType": "STORY",
        "title": "Why Abivax Stock Was on Fire Today",
        "description": "",
        "summary": "Investors were excited about the possibility of a buyout with a high price tag.",
        "pubDate": "2025-12-23T00:29:18Z",
        "displayTime": "2025-12-23T00:29:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/bf90746a10c9f788c7f13ae8f4931b45",
          "originalWidth": 1400,
          "originalHeight": 935,
          "caption": "Person in white lab coat inspecting pharmacy shelves.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RpHO07p4Wy7kIzvpj1E8tA--~B/aD05MzU7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/bf90746a10c9f788c7f13ae8f4931b45.cf.webp",
              "width": 1400,
              "height": 935,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4orWm0qM6SFVqYvBE_TnGg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/bf90746a10c9f788c7f13ae8f4931b45.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/22/why-abivax-stock-was-on-fire-today/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-abivax-stock-fire-today-002918711.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]